Linkedin Twitter

COVID-19 Business Intelligence and Analysis for Clinical Laboratories, Pathology Groups and Hospital Administration

  • Home
  • Briefings
  • Regulation
  • Webinars
  • Special Reports
  • Recordings of Live Calls
  • Testing Data
  • About
Menu
  • Home
  • Briefings
  • Regulation
  • Webinars
  • Special Reports
  • Recordings of Live Calls
  • Testing Data
  • About
COVID-19 Briefings

Free COVID-19 STAT Intelligence Briefings Email Digest

Subscribe Now!
  • Home
  • Briefings
  • Regulation
  • Webinars
  • Special Reports
  • Recordings of Live Calls
  • Testing Data
  • About
Menu
  • Home
  • Briefings
  • Regulation
  • Webinars
  • Special Reports
  • Recordings of Live Calls
  • Testing Data
  • About
Linkedin Twitter

Reliable COVID-19 Business Intelligence and analysis for clinical laboratories, pathology groups and Laboratory Diagnostics.

Day: June 1, 2021

FDA Warns Against Using COVID-19 Antibody Testing to Evaluate for Immunity After COVID-19 Vaccination

FDA maze of regulations

Despite considerable and growing interest in COVID-19 antibody testing for vaccinated individuals, the FDA’s new guidance seems to exclude such testing.

New Details Emerge About Origins of SARS-CoV-2, Questioning Whether Pandemic Was Caused by a Laboratory Accident

Clinical laboratories and meta-analysis recently published casts doubts on serology test performance, Abbott antigen test

Recent shift in perspective and openness to theories about SARS-CoV-2 origins mean that the truth behind the COVID-19 pandemic will eventually be discovered.

More COVID-19 Coverage Can Be Found in THE DARK REPORT
  • Home
  • Briefings
  • Regulation
  • Webinars
  • Special Reports
  • Recordings of Live Calls
  • Testing Data
  • About
Menu
  • Home
  • Briefings
  • Regulation
  • Webinars
  • Special Reports
  • Recordings of Live Calls
  • Testing Data
  • About

Copyright 2020 © The Dark Report. All rights reserved. The Dark Intelligence Group • 21806 Briarcliff Dr • Spicewood, TX 78669

  • Phone: 512-264-7103
Linkedin Twitter